JAGSNPHARMNSEJagsonpal Pharmaceuticals Limited· PharmaceuticalsLowNeutral
Announced Mon, 16 Jun · 17:29 IST

Jagsonpal Pharmaceuticals Limited has informed the Exchange about Schedule of meet

Board & Shareholder Meetings View source PDF

JAGSNPHARM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Jagsonpal Pharmaceuticals has informed the exchanges that its representatives will attend the GIA Promoter's Conference 2025, a group conference for analysts and institutional investors. The meeting is scheduled for Thursday, 26th June 2025, from 10:00 AM to 6:00 PM IST at St. Regis, Mumbai, and will be held in person. The company has clarified that only publicly available information will be discussed and no unpublished price-sensitive information (UPSI) will be shared. The schedule is subject to change based on exigencies.

Likely market impact

This is a routine investor engagement activity and is unlikely to have a direct impact on the stock price, as the company has explicitly stated that no new or price-sensitive information will be disclosed. Shareholders should treat this as a standard compliance disclosure with no material trigger.